Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approach

Conclusion:
Beta-blockade, particularly with atenolol, appears to successfully treat, if not resolve, recurrent hemoptysis refractory to conservative therapy in CF. Beta-blocker therapy appears to maintain an effective safety profile in CF.

Source: Therapeutic Advances in Respiratory Disease - August 6, 2013 Category: Respiratory Medicine Authors: Moua, J., Nussbaum, E., Liao, E., Randhawa, I. S. Tags: Original Research Source Type: research